A B S T R A C T Both cholera enterotoxin and certain
sine monophosphate (cyclic AMP), and to activate intestinal mucosal adenyl cyclase. It has been suggested that the effects of the enterotoxin on intestinal cyclic AMP metabolism may be indirect, and that locally synthesized prostaglandins may serve as required intermediates for the effects of the enterotoxin in activating intestinal mucosal adenyl cyclase. In order to clarify certain aspects of the mechanisms by which these two agents alter intestinal mucosal cyclic AMP metabolism and ion transport, their effects on cyclic AMP accumulation in rabbit ileal mucosa were examined in vitro. Addition of 5 Ag per ml (75 Ag per 150 mg mucosa) of purified cholera enterotoxin produced a peak increase in cyclic AMP level in 3 h but there was a time delay of at least 30 min before any effect was observed. Inhibition of cyclic nucleotide 'phosphodiesterase with theophylline failed to reduce this time delay. In contrast, addition of prostaglandin E1 (PGE1) increased the cyclic AMP level rapidly, a peak effect being observed in 2 min. The time of the peak prostaglandin-induced changes in cyclic AMP level and short-circuit current correlated closely. A maximal increment in cyclic AMP level was achieved with 5 X 10' M PGE1. When 10' M PGE1 was added to mucosa already maximally stimulated with cholera toxin, the resulting cyclic AMP. level was equal to the Dr. Kimberg is the recipient of a Research Career Development Award, AM-19377. Received for publication 29 March 1973 and in revised form 24 August 1973. sum of the levels reached when each agent was added alone. Furthermore, the effects of the enterotoxin on mucosal cyclic AMP levels were not influenced by indomethacin under conditions where mucosal prostaglandins synthesis was inhibited. The results suggest that endogenous prostaglandins do not provide an essential link in the activation of intestinal mucosal adenyl cyclase by cholera enterotoxin. The present study also indicates that the effect of cholera enterotoxin on intestinal mucosal cyclic AMP metabolism involves a definite time delay which is not due to cyclic nucleotide phosphodiesterase activity.
INTRODUCTION
There has been a great deal of recent interest in elucidating the mechanism of action of cholera enterotoxin in the intestine (see references 1-3 for reviews). It is now known that the massive outpouring of fluid and electrolyte is of small intestinal origin (4, 5) , that it occurs in the absence of significant alterations in small bowel morphology (6, 7) , and that an active secretory process provides the driving force for these intestinal losses (8) (9) (10) . Several recent studies strongly suggest that cholera enterotoxin produces its effects by stimulating intestinal mucosal adenyl cyclase, thereby altering the concentration of cyclic 3',5'-adenosine monophosphate (cyclic AMP)1 (11) (12) (13) . Both cyclic AMP and cholera enterotoxin have similar effects on ion transport when added in vitro to isolated ileal mucosa (10- 1Abbreviations used in this paper: cyclic AMP, cyclic 3',5'-adenosine monophosphate; PG, prostaglandin; SCC, short-circuit current.
The Journal of Clinical Investigation Volume 53 March 1974-941-949 14) . Evidence has also been presented that the two agents act upon the same secretory mechanism (10). Furthernmore, clholera enterotoxin has been shown to increase adenyl cyclase activity and cyclic AMP levels in the intestinal mucosa with a time pattern similar to that of its effect on fluid transport (13, 15) .
The mechanism by which cholera enterotoxin activates intestinal mucosal a(lenyl cyclase is largely unknown. After addition of toxin, adenyl cyclase activity increases slowly over 2-4 h (11, 15) . There may also be an initial time lag of 15-45 min before any change in adenyl cyclase activity, cyclic AMIP level, or ion transport occurs (1-4, 10-13, 15) . Because of the inevitable difficuilty in mieasuring iniitial simall clhaniges, however, both the existence of suclh a time lag and its duration are uncertain. If an irreducible interval between contact of toxin with the mucosa and initiation of a cyclic AMP-related event does indeed exist, this fact has important implications with respect to the mechanism by whiclh the toxin acts. One possible explanation for a time lag is the presence of sufficient cyclic nucleotide phosphodiesterase activity to prevent the cyclic ANIP level from increasing in response to a small increment in adenyl cyclase activity. If that is the case, it should be possible to shorten the time lag by inhibiting phosphodiesterase activity with theophylline. Another possible explanation for a time lag is that cholera enterotoxin may affect the synthesis or degradation of another compound which interacts more directly with adenyl cyclase. The cellular level of this compound would first either have to increase or decrease sufficiently before a change in adenyl cyclase activity could occur. Aside from bacterial toxins, the prostaglandins are the only other group of compounds which has been shown to enhance intestinal mucosal adenyl cyclase (11, 12) and to stimulate small bowel wvater and electrolyte secretion.
The latter has been demonstrated both in vivo (16, 17) and in vitro (18) .
Recently, it was suggested that the effects of the enterotoxin on intestinal cyclic AMP metabolism may be indirect, with an increase in locally synthesized prostaglandins serving as the required intermediates responsible for activating mucosal cyclase (19, 20) . The previously reported additive effect of prostaglandin El (PGE,) and cholera enterotoxin on intestinal mucosal adenyl cyclase (11, 12) argues against this hypothesis, but, taken alone, this evidence is less than conclusive. Effects on the adenyl cyclase activity of broken-cell preparations may not be representative of events in the intact cell. Furthermore, neither of the two prior studies concerned with adenyl cyclase activity demonstrated that a maximally stimulating amount of toxin had been employed (11, 12 Corp., Fort Lee, N. J.). The residues were then dissolved in 2.0 ml of 50 mM sodium acetate buffer, pH 4.0. Recoveries of cyclic AMP extracted from the tissue were determined by counting 0.5-ml aliquots in 10 ml of Bray's solution (21) comparing the results to those obtained by counting aliquots of the original recovery marker diluted in 0.5 ml of the acetate buffer. Each sample was assayed in duplicate for cyclic AMP levels by the protein-kinase binding method described by Gilman (22) . The trichloroacetic acid precipitates were dissolved overnight in 5 ml of 1 N NaOH and the protein content was measured by the method of Lowry, Rosebrough, Farr, and Randall (23), using bovine serum albumin as a standard.
Prostaglandin measurements. In certain experiments described below, prostaglandin levels were measured in the medium recovered at the end of the incubation. These determinations were performed by Clinical Assays, Inc., Cambridge, Mass.4 by the radioimmunoassay procedure described by Levine, Gutierrez Cernosek, Morril, and Levine (24) and Gutierrez Cernosek, Morril, and Levine (25) .
Antibodies to PGF2. were produced by conjugation of this prostaglandin to poly-L-lysine with carbodiimide, followed by complexing with succinylated hemocyanin (25, 26) . The conjugates, emulsified in complete Freund's adjuvant were used for immunization of rabbits. As previously reported, immunization with PGE1 conjugates produced antibodies with PGB1 specificity (24) . Prostaglandins in 5 ml of incubation medium were extracted for 1 h at room temperature with an equal volume of a methylal-ethanol mixture (5:1). After separation, the methylal-ethanol mixture was 4We are grateful to Mr. Pierre-Yves Cathou and Mr. Thomas Eller of Clinical Assays, Inc. for performing the prostaglandin radioimmunoassays. air dried at 40°C, and the residue was suspended in 1.0 ml of 0.01 M Tris-HCl buffer, pH 7.4, containing 0.14 M NaCl, 1.5 X 10' M CaC12, 5.0 X 10-' M MgCl2, and 0.1% gelatin. The extract was dialyzed overnight against an equal volume of the buffered gelatin solution. 0.5 ml of the dialysate was treated by addition of NaOH (0.02 -N final concentration), and this was heated at 100°C for 5 min in order to convert any PGEs and PGAs in the sample to PGBs. Duplicate 0.1-nil aliquots of the NaOH-treated material were assayed for PGBs using a PGB,-specific antibody that cross reacts 1: 3 with PGB2. These measurements, therefore, reflect the presence of PGEs, PGAs, and PGBs, and they do not distinguish the relative quantities of each of these prostaglandins initially present in the samples. The prostaglandins measured by this method are referred to as "PGBs" in the results. Duplicate 0.1-ml aliquots of the nonalkali-treated dialysate were also assayed specifically for PGF2, as previously described (24) (25) (26) .
SCC measuremlents. The method for determining the SCC in segments of rabbit ileal mucosa stripped of muscularis and mounted in Ussing chambers has been previously described (27) .
Materials. Purified cholera enterotoxin2 was prepared in isotonic sodium chloride such that the stock solution contained 500 ,ug per ml. The effectiveness of the enterotoxin in increasing cyclic AMP levels seemed to vary with different lots of toxin or with the same lot upon storage. In order to minimize the effects of this variation on our results, the groups of ex.periments shown in each Prostaglandins, Cholera Enterotoxin, and the Intestine Statistics. Statistical analyses were performed by Students' t test for paired variates (28) .
RESULTS
Effects of cholera enterotoxin on cyclic AMP levels. In initial experiments, ileal mucosa was incubated in the presence of varying concentrations of cholera enterotoxin for periods up to 3 h in order to establish the characteristics of the mucosal cyclic AMP response. As shown in Fig. 1 , no increase in cyclic AMP level developed for the first 30 min after addition of toxin, even with the highest toxin concentration employed (5.0 ug per ml). Thereafter, the rate of cyclic AMP accumulation with time varied directly withl toxin concentration.
By the enid of 2 h of incubation, the cyclic AMP conicentration appears to have reached a plateau in the presence of 5.0 stg per ml of toxin, but was clearly still rising at the lower two toxin concentrations.
In separate experiments, the effects of varying enterotoxin concentratiolns on cyclic AMP levels were coll1-pared at 3 anid 4 h (Fig. 2) . The cyclic AMP concenitration was not significantly higher at 4 than at 3 h in the presence of 5.0 gg per ml of toxin, but rose signiificantly (lurinig the 4tlh h in the preselnce of 1.0 and 0.1 Ag per ml of toxin. Also of niote is the observationi that by the end of 4 h of incubation there was no significant difference in the cyclic AMP levels achieved by incubation with 5.0 vs. 1.0 ug per ml of enterotoxin.
Since no detectable increase in cyclic AMP level developed during the first 30 min of exposure to cholera toxin, experiments were undertaken to determine whether inhibition of cyclic nucleotide phosphodiesterase activity with theophylline would result in an earlier detectable increase in cyclic AMP level. These experiments are summarized in Table I . It can be seeni that 2--3 hi after addition of toxin in vitro, the cyclic AMP level was three-to fourfold greater in mucosa treated with both toxin and theophylline than in mucosa treated with either agent alone. 30 min after toxin addition, however, the increase in cyclic AMP level produced by theophylline was no greater in toxin-treated than in control mnucosa. Therefore, inhibition of cyclic nucleotide phlosphodiesterase does not reduce the observed 30-min time lag.
Effects of PGE1 on cyclic AMP levels and SCC. As shown in Fig. 3 , PGE1 (10-' M) produces a detectable increase in ileal mucosal cyclic AMP concentration within 2 min, and this effect remains near maximal between 2 and 5 min. The results in Fig. 3 are also of interest, in that they show that the peak change in SCC occurs almost at the same point in time. Fig. 4 shows the effects of varying concentrations of PGE1 on cyclic AMP levels. A maximal effect appears to have been achieved at a concentration of 5.0 X 10-' M.
Additive effects of cholera enterotoxin and PGE,. In the studies just described, it had been determined that a 3-4-h incubation with cholera enterotoxin at a concentration of 5.0 s.g per ml consistently produced a maximal cholera eniterotoxin-related cyclic AMP response. Similarly, a 5-min exposure of ileal mucosa to 10-' M PGE1 produced a maximal PGEl-related response. In order to determine the effect of prior addition of cholera enterotoxin on the subsequent response to PGE1, tissues were preincubated in four flasks for 30 min at 37°C in Krebs-Ringer buffer, after which cholera enterotoxin (5.0 Ag per ml) was added to two of the (26, 29) and others (30) demonstrated that the anti-inflammatory drugs, indomethacin and acetylsalicylic acid, can effectively interfere with the synthesis of prostaglandins in guinea pig lung, canine spleen, and human platelets. In the lung homogenate system, the 50%l -inhibitory concentrations for indomethacin and acetylsalicylic acid were 7.5 X 10' M and 3.5 X 10' M, respectively (26) . In the platelet system, the concentration of acetylsalicylic acid causing 50% inhibition of prostaglandin production was somewhat lower (1.7 X 10' M), and indomethacin was only 10 times more effective than acetylsalicylic acid (30) .
Endogenous prostaglandin biosynthesis occurs in the small intestine (31, 32) . To explore further the possibility that cholera enterotoxin's effects on intestinal mucosal adenyl cyclase may be mediated by an enterotoxin-induced enhancement in endogenous prostaglandin synthesis, the effects of indomethacin and acetylsalicylic acid were examined in this system. In order to establish incubation conditions for these studies, it was first necessary to demonstrate that neither aspirin nor indomethacin inhibited the cyclic AMP response to exogenous PGE1 under the conditions to be employed. As shown at the top of Table III, Effects of indomethacin, acetylsalicylic acid, and cholera enterotoxin on prostaglandin levels. In a number of tissues studied, the release of prostaglandins into the medium proved to be a good measure of the rate of synthesis (29, 30, 33) . In order to explore more directly the effects of cholera enterotoxin, indomethacin, and acetylsalicylic acid on prostaglandin biosynthesis in ileal mucosa, experiments were performed in which the effects of these agents on prostaglandin accumulation in the medium were examined. Effects on tissue cyclic AMP levels were determined simultaneously. In these experiments, three pieces of ileal mucosa were preincubated for 30 min at 37°C in each of six flasks, pairs of which contained either indomethacin, acetylsalicylic acid, or the appropriate solvents. On the basis of studies in other tissues, a 30-min preincubation should have been sufficient for the tissue prostaglandin initially present to have been released and for the anti-inflammatory drugs to have exerted an inhibitory effect on de novo prostaglandin synthesis (29) . After preincubation, the tissues were transferred to other flasks containing fresh medium with the same additions. At this time, cholera enterotoxin was added to one control flask, one indomethacincontaining flask, and one acetylsalicylic acid-containing flask. After an additional 2 h of incubation, the experiment was terminated, tissues were rapidly removed for cyclic AMP assay, and media were frozen for subsequent determination of prostaglandin levels. Results are given in Table IV . Neither of the inhibitors of prostaglandin biosynthesis prevented the cholera enterotoxin effect on cyclic AMP levels, findings consistent with those already presented. Base line levels of "PGB" and PGF2. were lowered by incubation in the presence of indomethacin, whereas acetylsalicylic acid in the concentration employed did not seem to exert a consistent effect. Of principal importance for the present study is the observation that indomethacin, at a concentration which consistently and markedly inhibits prostaglandin biosynthesis by the intestinal mucosa, fails to inhibit the enterotoxin-induced cyclic AMP rise.
DISCUSSION
There are certain observations regarding the intestinal effects of cholera enterotoxin and the interrelationship between hormones and prostaglandins in other tissues which suggest a possible role for endogenously synthesized prostaglandins as mediators for the enterotoxins' effects on intestinal mucosal adenyl cyclase activity. Thus, as other studies have suggested (1, (11) (12) (13) and the present study confirms, there is an unexplained delay in the onset of the enterotoxin's effect on adenyl cyclase activity in the intestine. It has also been suggested that prostaglandins miay serve as modulators of hormone action in the toad bladder (34) and that endogenous prostaglandin synthesis or release may provide an essential link in the effects of luteinizing hormone on adenyl cyclase activity in mouse ovary (35) .
Recently, Jacoby and Marshall (36) reported that the administration of acetylsalicylic acid, indomethacin, phenylbutazone, sodium salicylate, or glucocorticoids is associated with a decrease in the amount of fluid accumulated in small intestinal loops in rats 4 h after intraluminal challenge with cholera enterotoxin. Subsequently, Finck and Katz (37) demonstrated in cats that the intravenous administration of acetylsalicylic acid prevents the accumulation of fluid in jejunal loops in vivo after exposure of the mucosa to cholera enterotoxin. Although the in vivo administration of anti-inflammatory agents capable of inhibiting prostaglandin biosynthesis may be associated with inhibition of cholera enterotoxin-induced intestinal fluid accumulation, the results of the present in vitro studies strongly suggest that the prostaglandins do not provide an essential link in the activation of intestinal mucosal adenyl cyclase by cholera toxin. Thus, indomethacin markedly inhibited prostaglandin biosynthesis in rabbit ileal mucosa, but failed to reduce the magnitude of the cyclic AMP response to toxin. Furthermore, when maximally stimulating amounts of both cholera toxin and PGEi were added to the mucosa, the effect on mucosal cyclic AMP level was additive.
Additional evidence supporting the hypothesis that prostaglandins do not mediate the effects of the enterotoxin on intestinal mucosal cyclic AMP metabolism is provided by the recent studies of Bourne (38) , dealing with the effects of the toxin on leukocyte cyclic AMP levels, as well as other experiments concerned with the effects of the toxin on cyclic AMP metabolism in turkey erythrocytes. Bourne (38) has shown that neither acetylsalicylic acid nor indomethacin interferes with the ability of cholera enterotoxin to increase cyclic AMP levels in lhumiian leukocytes. His observations are entirely con- A few additional observations resulting from the present study deserve comment. The effect of PGE1 on SCC appears to be a consequence of its effect on cyclic AMP metabolism. Both cyclic AMP level and SCC increase to a peak level in the first 2 min after addition of prostaglandin. A rapid increase in SCC also occurs upon addition of theophylline, cyclic AMP, or dibutyryl cyclic AMP (14) . The fact that purified cholera toxin produces a much smaller increase (in SCC (10) can be attributed to its delayed and gradual effect on cyclic AMP level. The initial large increases in SCC produced by cyclic AMP and theoplhylline decrease considerably with time (14) . This is also true for PGE1 (see Fig. 3 ). The exact ionic comlpolnents of the early SCC response to the prostaglandin's, to theophl ylline, an(d to cyclic AMP itself have not been established. The SCC inicrease may reflect an active secretion of anioIn (Cl or HCO3), but a paradoxical early stimulation of active Na absorption, which is later replaced by secretory changes, has not been excluded.
The present study also provides evi(lenice that thlere is anl uinavoidahle delay of at least 30 min betwen additioni of cholera toxin and a demonstrable increase in cyclic AMP level. This proved to be the case even upon addition of the comparatively huge dose of 5 iAg per ml of toxin (or 75 pg per 150 mg of mucosal wet weight). Furthermore, inhibition of phosphodiesterase activity with theophylline did not shorten this delay. The reasonl for the delay remain's to be established. It is clearly not due to a primary effect on prostaglandin biosynthesis. It is probably also not due to an induction of protein synthesis, since cycloheximide does not block the effect of cholera toxin on adenyl cyclase (40) .
